Shares outstanding increased 24.4%
Shares outstanding changed +24.4% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +24.4% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Trade receivables changed -25.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed -9.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -8.5% from the comparable as-filed period.
Receivables / revenue changed +8826 basis points from the comparable as-filed period.
Research & development changed +3.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.